Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,437 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Cancer associated thrombosis in everyday practice: perspectives from GARFIELD-VTE.
Weitz JI, Haas S, Ageno W, Goldhaber SZ, Turpie AGG, Goto S, Angchaisuksiri P, Nielsen JD, Kayani G, Farjat AE, Schellong S, Bounameaux H, Mantovani LG, Prandoni P, Kakkar AK; GARFIELD-VTE investigators. Weitz JI, et al. Among authors: haas s. J Thromb Thrombolysis. 2020 Aug;50(2):267-277. doi: 10.1007/s11239-020-02180-x. J Thromb Thrombolysis. 2020. PMID: 32583306
Workshop II: The future of prolonged thromboprophylaxis.
Haas S, Agnelli G, Arcelus JI, Davidson BL, Lassen MR, Planés A. Haas S, et al. Blood Coagul Fibrinolysis. 1999 Aug;10 Suppl 2:S103-6. Blood Coagul Fibrinolysis. 1999. PMID: 10493238 Review. No abstract available.
[Home treatment for deep vein thrombosis: pros and cons].
Bauersachs R, Haas S, Schellong S. Bauersachs R, et al. Among authors: haas s. Hamostaseologie. 2004 Aug;24(3):167-72. doi: 10.1267/hamo04030167. Hamostaseologie. 2004. PMID: 15314701 Review. German.
[Bridging anticoagulation].
Schellong SM, Halbritter K, Haas S. Schellong SM, et al. Among authors: haas s. Chirurg. 2007 Feb;78(2):125-6, 128-32. doi: 10.1007/s00104-006-1290-4. Chirurg. 2007. PMID: 17252252 Review. German.
Dose-escalation study of rivaroxaban (BAY 59-7939)--an oral, direct Factor Xa inhibitor--for the prevention of venous thromboembolism in patients undergoing total hip replacement.
Eriksson BI, Borris LC, Dahl OE, Haas S, Huisman MV, Kakkar AK, Misselwitz F, Muehlhofer E, Kälebo P. Eriksson BI, et al. Among authors: haas s. Thromb Res. 2007;120(5):685-93. doi: 10.1016/j.thromres.2006.12.025. Epub 2007 Feb 12. Thromb Res. 2007. PMID: 17292948 Clinical Trial.
1,437 results